Physician profile
James C Gardner
NPI 1255447330
$1,694.58
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $196 · 2021: $232 · 2022: $67.38 · 2023: $253 · 2024: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.50 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $474.35 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $137.37 | 2019-2020 | |
| Amgen INC. | $121.11 | 2019 | |
| Novo Nordisk INC | $118.26 | 2024 | |
| Endo Pharmaceuticals INC. | $111.92 | 2019 | |
| Astellas Pharma US INC | $107.01 | 2019-2024 | |
| Allergan, INC. | $88.69 | 2019-2020 | |
| Lilly USA, LLC | $81.32 | 2019-2020 | |
| Pfizer INC. | $74.78 | 2019-2020 | |
| Biomarin Pharmaceutical INC. | $68.00 | 2021 | |
| Amarin Pharma, INC. | $46.18 | 2020 | |
| Esperion Therapeutics, INC. | $41.36 | 2021 | |
| Amag Pharmaceuticals, INC. | $40.45 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.94 | 2019 | |
| Boston Scientific Corporation | $24.24 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $23.68 | 2019 | |
| Merck Sharp & Dohme LLC | $20.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.18 | 2019 | |
| Therapeuticsmd, INC. | $17.95 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.43 | 2020 | |
| Arbor Pharmaceuticals, INC. | $16.55 | 2019 | |
| Daiichi Sankyo INC. | $14.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.